You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CASE REPORT article

Front. Med., 18 November 2025

Sec. Dermatology

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1686909

Case Report: Imaging findings in sneaky subungual amelanotic melanoma

  • 1. Department of Ultrasound, Zhejiang Hospital, Hangzhou, China

  • 2. The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

  • 3. Department of Pathology, Zhejiang Hospital, Hangzhou, China

Article metrics

View details

1k

Views

54

Downloads

Abstract

We report a rare case of solitary subungual malignant melanoma in a female patient who presented with a misaligned nail without accompanying pigmentary changes. The absence of typical clinical and imaging features delayed definitive diagnosis. Both magnetic resonance imaging (MRI) and ultrasound (US) initially suggested a benign lesion, favoring subungual telangiectatic granuloma. However, histopathology ultimately confirmed subungual melanoma with negative Human Melanoma Black-45 (HMB-45) immunostaining. Amelanotic melanomas are particularly prone to misdiagnosis or delayed recognition due to their lack of visible pigmentation. We present a detailed analysis of the imaging and pathological findings, highlighting specific ultrasound characteristics, with the aim of providing a valuable reference for the clinical diagnosis and management of such uncommon cases.

Introduction

Subungual melanoma (SUM), a rare variant of acral melanoma, predominantly occurs in the thumb and great toes of adults aged 50–70 years (1). Amelanotic melanoma, an uncommon histologic subtype, constitutes a small proportion of all melanomas. While it most commonly occurs in sun-exposed regions such as the ears, nose, and face, it is far less frequent in the subungual area (2). Currently, the primary diagnostic modalities for subungual melanoma include dermoscopy, magnetic resonance imaging, ultrasound examination, and pathological biopsy. We present a case of subungual amelanotic melanoma, where its atypical clinical presentation and Human Melanoma Black-45 (HMB-45) negativity pose diagnostic challenges, ultimately leading to a misdiagnosis of subungual telangiectatic granuloma. This case report was conducted in accordance with ethical standards. Written informed consent was obtained from the patient and approved by the Ethics Committee of Zhejiang Hospital (Ethics Approval No. 2025-CA-34).

Case description

A 52-year-old woman presented to the dermatology department with complaints of longitudinal splitting and bleeding of her left thumbnail, without any history of trauma. The distal portion of the left thumbnail appeared swollen, and a rice-sized mass was observed between the split nails, which was mildly tender to the touch. Neither the epidermis nor the nail showed any blackening or discoloration (Figure 1). She had been treated with topical antifungal lacquer for 2 months at a local hospital for a misaligned nail that had persisted for 1 year.

Figure 1

Three-panel image showing a thumb with varying scar severity. Panel A shows a thumb with a nail and scarring. Panel B displays more pronounced scarring and thicker skin. Panel C illustrates a thumb with smooth, less visible scarring, indicating healing progression. Each panel includes a 1-centimeter scale for reference.

Gross features. (A) Longitudinal splitting and bleeding of the left thumb nail, with a rice-like mass observed between the nail splits. (B) No signs of tumor recurrence in the left thumb, 6 months post-surgery. (C) No signs of tumor recurrence in the left thumb, 2 years post-surgery.

Magnetic resonance imaging (MRI) of the left hand revealed a flaky abnormal signal shadow on the dorsal side of the first distal phalanx. The lesion was low to moderate signal on T1-weighted imaging (T1WI), high signal on T2-weighted imaging (T2WI), and T2 fat suppression sequences (FSE) with well-defined borders. High signal with poorly defined borders on DWI sequences. The surrounding soft tissue was edematous, but there was no obvious destruction of the bone (Figure 2). High-frequency ultrasonography (14.3 MHz) revealed a well-defined low-echo nodule measuring approximately 0.62 × 0.38 × 0.61 cm, exhibiting highly abundant blood flow signals in color Doppler flow imaging (CDFI) (Figure 3).

Figure 2

MRI images showing a hand and finger in various views with arrows indicating specific areas of interest in each image. Each image is marked with a scale showing one centimeter for reference.

Magnetic resonance imaging findings. The lesion (indicated by the white arrow) exhibited the following characteristics: (a) Low to moderate signal intensity on oblique coronal (OCor) T1-weighted imaging (WI) fast spin echo. (b) High signal intensity on oblique coronal T2-weighted imaging (T2WI) and fat-suppressed proton density (fsPD). (c) High signal intensity in oblique sagittal T2WI fsPD. (d) High signal intensity in oblique axial (OAx) T2WI fsPD. (e) High signal intensity in OAx diffusion-weighted imaging (DWI). (f) Low signal intensity on the apparent diffusion coefficient (ADC) map.

Figure 3

Ultrasound images labeled a, b, c, and d. Images a and b show grayscale ultrasound scans with measurements indicated. Images c and d display color Doppler overlays indicating blood flow, with areas of red and blue highlighting different flow directions and velocities. Each image includes a 1 cm scale bar.

Ultrasound images. (a,b) A hypoechoic nodule with well-defined borders is located beneath the thumbnail. (c,d) Color Doppler flow images showing nodular microvascular enrichment.

We first considered benign lesions, favoring subungual telangiectatic granuloma. Subsequently, the patient underwent a local tissue biopsy. However, histopathological analysis confirmed a diagnosis of melanoma. The lesion showed diffusely infiltrative tumor cells in the fibrous tissue in patches or nests, which were relatively uniform in size, with a large, deeply stained nucleus, obvious atypia, and rare mitosis. No clear necrosis or pigment deposition was observed. Immunohistochemistry was positive for S-100 and SOX10 and negative for HMB45, smooth muscle actin, creatine kinase, and CD34 (Figure 4). Furthermore, the negative results for EMA, CD31, desmin, GATA3, PAX8, ER, PR, and P63 effectively rule out epithelial, vascular, smooth muscle-derived, and breast cancer tumors to a certain extent. Following clinical and pathological evaluation, the patient underwent extended resection of the local tumor without amputation, radiation, or chemotherapy, due to Breslow thickness of 2.1 mm and Clark level IV. The thumb was reconstructed using an autologous flap, which successfully preserved the distal phalanx. No recurrence was observed at 2-year postoperative follow-up, and the patient did not require adjuvant therapy.

Figure 4

Histological analysis showing six panels of stained tissue sections. Panel a and b use H and E staining, highlighting cell morphology and structure at different magnifications. Panel c and d show S-100 and SOX-10 staining, indicating presence of specific proteins with brown coloration. Panel e features HMB-45 staining, showing little to no protein presence. Panel f demonstrates SMA staining, revealing protein distribution with brown highlights. Each panel includes localized magnification scales in micrometers.

Histopathology. Hematoxylin and eosin staining reveals: (a) Atypical oval cells aggregated in patches or nests (50× magnification). (b) Large cells with high nuclear-to-cytoplasmic ratios, deeply stained, without obvious necrosis or pigment deposition (200× magnification). Immunohistochemical staining: (c) S-100 (100× magnification). (d) SOX-10 (100× magnification). (e) HMB-45 (100× magnification). (f) Smooth muscle actin (100× magnification).

At the 2-year follow-up, the patient demonstrated excellent functional and cosmetic outcomes. Tip pinch strength was 85% of the contralateral hand, with the affected left thumb exhibiting 3.6 kg of strength compared to 4.5 kg on the right. Thumb opposition was nearly complete, with a Kapandji score of 9/10, allowing the patient to perform fine motor activities, such as buttoning and flipping pages, without difficulty. The surgical scar was minimally noticeable, with a Vancouver Scar Scale score of 3, and the patient reported a high level of satisfaction with the aesthetic result (9/10 on a numerical rating scale) (Figure 1).

Discussion

Subungual melanoma (SUM), a rare variant of acral melanoma, accounts for 1.0–1.7% of cutaneous melanomas in Europe and 7.1–29.3% of all melanomas in Asia (3, 4). Due to its high malignancy, subtle clinical presentation, and difficulty of early diagnosis, distant metastasis is common, which often results in poor prognosis (5). Early detection and complete surgical excision remain the cornerstone for achieving a curative outcome in all types of melanoma. Delayed diagnosis is associated with increased Breslow depth, a higher risk of metastasis, and reduced survival. Amelanotic melanoma accounts for only a small proportion of all melanomas, and its occurrence in the subungual region is and is particularly uncommon in the subungual region (5). Its rarity, combined with the absence of pigmentation, significantly increases the risk of misdiagnosis. Additionally, studies have shown that, compared to pigmented melanoma, non-pigmented melanoma tends to have fewer specific white blood cells that identify and attack the tumor, which may suggest a poorer prognosis (6).

The diagnosis of subungual melanoma presents numerous challenges. While extensive literature documents such cases, the present case exhibits several distinctive features that set it apart from previously reported instances (7–10). First, acral amelanotic melanoma is rare, especially when it initially manifests in changes in nail morphology. Second, this case exhibits negative HMB-45 expression, which is also relatively uncommon as a highly specific indicator. Finally, detailed imaging data are presented, an aspect seldom emphasized in earlier reports.

Our case presented an unusual immunohistochemical profile—negative HMB-45 expression—which is particularly uncommon and may further obscure the correct diagnosis. HMB-45 is a highly specific immunohistochemical marker for melanoma. Multiple studies report that 56.3 to 77% of melanomas are HMB-45 positive, with a notably high prevalence also observed in amelanotic melanoma (11, 12). Although HMB-45 is widely used as a melanocytic marker, it may be absent in certain histologic variants or tumors with minimal melanin synthesis (13, 14). Relevant literature suggests that expression levels and gradients of HMB-45 are associated with the degree of differentiation and invasiveness in melanoma (15, 16). Therefore, when HMB-45 is negative, a broader immunohistochemical panel, including S-100, SOX10, creatine kinase, smooth muscle actin, and Melan-A, should be considered to ensure diagnostic accuracy (17, 18).

Clinically, subungual amelanotic melanoma often lacks specific or pathognomonic features during its early stages. This can cause patients to underestimate the significance of their symptoms and delay medical consultation. In our patient, the earliest presentation was misalignment of nail growth, likely caused by tumor invasion of the nail matrix. This clinical presentation initially raised dermatological concern without immediate suspicion of malignancy, but early histopathological evaluation ultimately established the definitive diagnosis. Fortunately, early pathological evaluation led to an accurate diagnosis, with a Breslow thickness of 2.1 mm and Clark level IV, and a negative sentinel lymph node biopsy, allowing for a procedure that preserved both hand function and cosmetic appearance.

Radiologic evaluation of small or atypical tumors of the hand remains challenging. While MRI is an important modality for assessing the extent of soft tissue lesions, its diagnostic sensitivity to melanoma decreases when melanin content is low. Melanin shortens both T1 and T2 relaxation times, which produces a characteristic high signal on T1-weighted and low signal on T2-weighted sequences. In amelanotic melanoma, these features are absent, resulting in non-specific MRI findings (19–21). In our case, MRI did not detect the melanoma, most likely due to the absence of melanin pigmentation and the small size of the tumor.

In contrast, high-frequency ultrasound may provide superior resolution in this case. Ultrasound provides high spatial resolution for superficial lesions and allows real-time evaluation of tumor vascularity using CDFI. Upon reviewing and analyzing the images, we observed that extremely hypoechoic areas of the tumor based on two-dimensional images, with CDFI demonstrating pedicle-like vascular flow signals. These findings suggest an unbalanced and disorganized tumor blood supply, which is more characteristic of malignant lesions than benign subungual masses.

Comparing the two imaging modalities, high-frequency ultrasound excels in spatial resolution, making it particularly effective for evaluating superficial areas such as the subungual region. It provides detailed information on lesion size, morphology, and vascular characteristics (22, 23). However, its ability to assess deeper tissues is limited. In contrast, MRI offers a more comprehensive view of lesion depth and the surrounding structures, although its sensitivity may be reduced when detecting subtle vascular changes or small, non-pigmented lesions. Therefore, clinicians should recognize the complementary roles of these two imaging techniques in the diagnosis of subungual melanoma.

The main imaging differential in this case was subungual telangiectatic granuloma, a benign reactive lesion that arises secondary to chronic irritation, trauma, or infection (24, 25). This lesion typically appears hypervascular on Doppler imaging and hypoechoic on grayscale ultrasound. Due to these similarities, subungual amelanotic melanoma may be misdiagnosed as telangiectatic granuloma, particularly when pigmentation is absent. However, the presence of heterogeneous hypoechoic zones, irregular tumor margins, and pedicle-like vascular patterns can help differentiate melanoma from benign vascular lesions.

From a clinical management perspective, it is crucial to avoid empirical treatments that may obscure the underlying diagnosis. For example, topical antifungal agents can cause hypopigmentation of the nail or periungual tissue, potentially masking early melanoma and causing diagnostic delays. Melanoma should be suspected in nail bed masses, especially those in the thumbs or toes with microvascular enrichment and with or without hyperpigmentation, or a positive Hutchinson’s sign.

Based on our experience and a review of the literature, we recommend the following strategies to improve early detection of subungual amelanotic melanoma (26–33):

  • To maintain a high index of suspicion for persistent nail bed masses, especially those affecting the thumb or great toe, regardless of pigmentation status.

  • To utilize dermoscopy and high-frequency ultrasound as first-line imaging modalities for detailed structural and vascular assessment.

  • To perform histopathological examination early, and if HMB-45 is negative, use an extended immunohistochemical panel to improve diagnostic accuracy.

  • To consider genetic testing in diagnostically challenging cases to identify carcinogenic mutations and guide subsequent treatment.

In summary, this case underscores the diagnostic challenges of subungual amelanotic melanoma, particularly in the setting of HMB-45 negativity. It highlights the limitations of MRI for small, non-pigmented tumors and the potential advantages of high-frequency ultrasound in identifying subtle yet distinctive vascular and echotextural features. Prompt integration of imaging, pathology, and immunohistochemistry is essential to avoid misdiagnosis and to enable timely, function-preserving surgical management.

Statements

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.

Ethics statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.

Author contributions

MS: Conceptualization, Validation, Investigation, Writing – review & editing, Methodology, Visualization, Data curation, Writing – original draft, Resources. MZ: Data curation, Resources, Writing – original draft, Investigation, Writing – review & editing, Validation, Methodology. XZ: Conceptualization, Validation, Writing – original draft. XS: Resources, Writing – review & editing, Project administration, Supervision. XD: Data curation, Validation, Writing – original draft, Supervision. ZD: Writing – review & editing, Investigation, Writing – original draft, Conceptualization, Visualization, Data curation, Resources. BH: Resources, Supervision, Validation, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Acknowledgments

We are indeed grateful to thank the patient in this case for her support and understanding.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    Levit EK Kagen MH Scher RK Grossman M Altman E . The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. (2000) 42:26974. doi: 10.1016/S0190-9622(00)90137-3

  • 2.

    Farberg AS Marson JW Glazer A Litchman GH Svoboda R Winkelmann RR et al . Expert consensus on the use of prognostic gene expression profiling tests for the Management of Cutaneous Melanoma: consensus from the skin Cancer prevention working group. Dermatol Ther (Heidelb). (2022) 12:80723. doi: 10.1007/s13555-022-00709-x

  • 3.

    Ahn SY Bae GE Park SY Yeo MK . Differences in the clinical and molecular profiles of subungual melanoma and acral melanoma in Asian patients. Cancer. (2023) 15:4417. doi: 10.3390/cancers15174417

  • 4.

    Tsiogka A Rubin AI Gregoriou S Soulaidopoulos S Belyayeva H Rigopoulos D . Prevalence of subungual melanoma in patients with cutaneous malignant melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. (2024) 38:7783. doi: 10.1111/jdv.19482

  • 5.

    Tan KB Moncrieff M Thompson JF McCarthy SW Shaw HM Quinn MJ et al . Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting. Am J Surg Pathol. (2007) 31:190212. doi: 10.1097/PAS.0b013e318073c600

  • 6.

    Choi ME Choi EJ Lee JH Won CH Chang SE Lee MW et al . Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants. Br J Dermatol. (2024) 191:58091. doi: 10.1093/bjd/ljae224

  • 7.

    Mohammed Saeed D Braniecki M Groth JV . A rare case of acral amelanotic melanoma, nodular type. Int Wound J. (2019) 16:14459. doi: 10.1111/iwj.13212

  • 8.

    Cassalia F Danese A Cocchi E Danese E Ambrogio F Cazzato G et al . Misdiagnosis and clinical insights into acral amelanotic melanoma-a systematic review. J Pers Med. (2024) 14:518. doi: 10.3390/jpm14050518

  • 9.

    Zhang J Yang H Lin J Zhang F Shi J Chen R . Primary acral amelanotic melanoma: a rare case report. Mol Clin Oncol. (2020) 13:1. doi: 10.3892/mco.2020.2129

  • 10.

    An L Liu Z Chen X Jia Y . Rare subungual amelanotic melanoma presenting as prolonged swelling and exudation after trauma: case report and literature review. Front Immunol. (2025) 16:1661698. doi: 10.3389/fimmu.2025.1661698

  • 11.

    Clarkson KS Sturdgess IC Molyneux AJ . The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-a). J Clin Pathol. (2001) 54:196200. doi: 10.1136/jcp.54.3.196

  • 12.

    Rasic D Korsgaard N Marcussen N Precht Jensen EM . Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors. Ann Diagn Pathol. (2023) 67:152211. doi: 10.1016/j.anndiagpath.2023.152211

  • 13.

    Ito T Hashimoto H Kaku-Ito Y Tanaka Y Nakahara T . Nail apparatus melanoma: current management and future perspectives. J Clin Med. (2023) 12:2203. doi: 10.3390/jcm12062203

  • 14.

    Hughes TM Williams GJ Gyorki DE Kelly JW Stretch JR Varey AHR et al . Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelines. J Eur Acad Dermatol Venereol. (2021) 35:12908. doi: 10.1111/jdv.17154

  • 15.

    Ricci C Dika E Ambrosi F Lambertini M Veronesi G Barbara C . Cutaneous melanomas: a single center experience on the usage of immunohistochemistry applied for the diagnosis. Int J Mol Sci. (2022) 23:5911. doi: 10.3390/ijms23115911

  • 16.

    Voiculescu VM Popescu AI Costache M . Immunohistochemistry for skin cancers: new insights into diagnosis and treatment of melanoma. Cancers (Basel). (2025) 17:1769. doi: 10.3390/cancers17111769

  • 17.

    Zhou L Zhou Q Guo Q Lai P Rui C Li W et al . Dual role of Cathepsin S in cutaneous melanoma: insights from mendelian randomization and bioinformatics analysis. BMC Cancer. (2025) 25:104. doi: 10.1186/s12885-025-13481-w

  • 18.

    Liu H Xue H Guo Q Xue X Yang L Zhao K et al . Ferroptosis meets inflammation: a new frontier in cancer therapy. Cancer Lett. (2025) 620:217696. doi: 10.1016/j.canlet.2025.217696

  • 19.

    Trehan SK Athanasian EA DiCarlo EF Mintz DN Daluiski A . Characteristics of glomus tumors in the hand not diagnosed on magnetic resonance imaging. J Hand Surg Am. (2015) 40:5425. doi: 10.1016/j.jhsa.2014.12.002

  • 20.

    Al-Qattan MM Al-Namla A Al-Thunayan A Al-Subhi F El-Shayeb AF . Magnetic resonance imaging in the diagnosis of glomus tumours of the hand. J Hand Surg Br. (2005) 30:53540. doi: 10.1016/j.jhsb.2005.06.009

  • 21.

    Baek HJ Lee SJ Cho KH Choo HJ Lee SM Lee YH et al . Subungual tumors: clinicopathologic correlation with US and MR imaging findings. Radiographics. (2010) 30:162136. doi: 10.1148/rg.306105514

  • 22.

    Heibel HD Hooey L Cockerell CJ . A review of noninvasive techniques for skin Cancer detection in dermatology. Am J Clin Dermatol. (2020) 21:51324. doi: 10.1007/s40257-020-00517-z

  • 23.

    Laverde-Saad A Simard A Nassim D Jfri A Alajmi A O’Brien E et al . Performance of ultrasound for identifying morphological characteristics and thickness of cutaneous basal cell carcinoma: a systematic review. Dermatology. (2022) 238:692710. doi: 10.1159/000520751

  • 24.

    Silva-Feistner M Ortiz E Alvarez-Véliz S Wortsman X . Amelanotic Subungual Melanoma Mimicking Telangiectatic Granuloma: Clinical, Histologic, and Radiologic Correlations. Melanoma amelanótico subungueal simulando granuloma telangiectásico. Correlación clínica, histológico y radiológica. Actas Dermosifiliogr. (2017) 108:785787. doi: 10.1016/j.ad.2017.03.008

  • 25.

    Wollina U . Subungual telangiectatic granuloma. Dtsch Arztebl Int. (2017) 114:136. doi: 10.3238/arztebl.2017.0136

  • 26.

    Temple-Oberle C Nicholas C Rojas-Garcia P . Current controversies in melanoma treatment. Plast Reconstr Surg. (2023) 151:495e505e. doi: 10.1097/PRS.0000000000009936

  • 27.

    Neczyporenko F André J Torosian K Theunis A Richert B . Management of in situ melanoma of the nail apparatus with functional surgery: report of 11 cases and review of the literature. J Eur Acad Dermatol Venereol. (2014) 28:5507. doi: 10.1111/jdv.12131

  • 28.

    Goettmann S Moulonguet I Zaraa I . In situ nail unit melanoma: epidemiological and clinic-pathologic features with conservative treatment and long-term follow-up. J Eur Acad Dermatol Venereol. (2018) 32:23006. doi: 10.1111/jdv.15124

  • 29.

    Thakker S Jaguan D Belzberg M Gulati N Campbell JR DeClerck BK et al . Acral lentiginous melanoma. Part I. epidemiology, etiology, clinical presentation, and diagnosis. J Am Acad Dermatol. (2025). doi: 10.1016/j.jaad.2024.10.124

  • 30.

    Aung TN Liu M Su D Shafi S Boyaci C Steen S et al . Pathologist-read vs AI-driven assessment of tumor-infiltrating lymphocytes in melanoma. JAMA Netw Open. (2025) 8:e2518906. doi: 10.1001/jamanetworkopen.2025.18906

  • 31.

    Kim HJ Kim YH . Molecular Frontiers in melanoma: pathogenesis, diagnosis, and therapeutic advances. Int J Mol Sci. (2024) 25:2984. doi: 10.3390/ijms25052984

  • 32.

    Salih R Ismail F Orchard GE . Double Immunohistochemical labelling of PRAME and Melan a in slow Mohs biopsy margin assessment of Lentigo Maligna and Lentigo Maligna melanoma. Br J Biomed Sci. (2024) 81:12319. doi: 10.3389/bjbs.2024.12319

  • 33.

    Misiąg P Molik K Kisielewska M Typek P Skowron I Karwowska A et al . Amelanotic melanoma-biochemical and molecular induction pathways. Int J Mol Sci. (2024) 25:11502. doi: 10.3390/ijms252111502

Summary

Keywords

subungual ultrasound, amelanotic melanoma, subungual telangiectatic granuloma, skin tumor, case report

Citation

Shi M, Zhao M, Zhu X, Sun X, Dai X, Dong Z and Huang B (2025) Case Report: Imaging findings in sneaky subungual amelanotic melanoma. Front. Med. 12:1686909. doi: 10.3389/fmed.2025.1686909

Received

16 August 2025

Revised

04 November 2025

Accepted

04 November 2025

Published

18 November 2025

Volume

12 - 2025

Edited by

Qian Guo, First Affiliated Hospital of Zhengzhou University, China

Reviewed by

Rui Wang, University of Southern California, United States

Li Wang, University of California, San Francisco, United States

Updates

Copyright

*Correspondence: Bin Huang, ; Zeyang Dong,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics